Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment

Madan Raj Aryal; Rohit Gosain; Anthony Donato; Ranjan Pathak; Vijaya Raj Bhatt; Anjan Katel; Peter Kouides

doi:10.1007/s11886-020-01327-9

Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment

Madan Raj Aryal, Rohit Gosain, Anthony Donato, Ranjan Pathak, Vijaya Raj Bhatt, Anjan Katel, Peter Kouides

Research output: Contribution to journal › Review article › peer-review

2 Scopus citations

Abstract

Purpose of Review: Novel coronavirus disease 2019 (COVID-19) has been associated with an increased risk of arterial and venous thromboembolic (VTE) diseases. However, there is a limited amount of data regarding the prevention and management of VTE in severe hospitalized COVID-19 patients. Recent Findings: In this article, we review currently available clinical data, and mechanisms for COVID-associated coagulopathy, and propose algorithms for screening, prevention (including extended-duration prophylaxis), and treatment of these patients. Summary: Although these recommendations are subject to change given rapidly evolving data, we provide a framework that can guide clinicians in managing thrombotic complications in this challenging condition.

Original language	English (US)
Article number	52
Journal	Current Cardiology Reports
Volume	22
Issue number	7
DOIs	https://doi.org/10.1007/s11886-020-01327-9
State	Published - Jul 1 2020

Keywords

COVID-19
Deep vein thrombosis
Extended prophylaxis
Pulmonary embolism
Thromboprophylaxis
Venous thromboembolism

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1007/s11886-020-01327-9

Fingerprint Dive into the research topics of 'Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment'. Together they form a unique fingerprint.

Cite this

@article{56c0a9f8d7ec4bd2b7de4e80de53c263,

title = "Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment",

abstract = "Purpose of Review: Novel coronavirus disease 2019 (COVID-19) has been associated with an increased risk of arterial and venous thromboembolic (VTE) diseases. However, there is a limited amount of data regarding the prevention and management of VTE in severe hospitalized COVID-19 patients. Recent Findings: In this article, we review currently available clinical data, and mechanisms for COVID-associated coagulopathy, and propose algorithms for screening, prevention (including extended-duration prophylaxis), and treatment of these patients. Summary: Although these recommendations are subject to change given rapidly evolving data, we provide a framework that can guide clinicians in managing thrombotic complications in this challenging condition.",

keywords = "COVID-19, Deep vein thrombosis, Extended prophylaxis, Pulmonary embolism, Thromboprophylaxis, Venous thromboembolism",

author = "Aryal, {Madan Raj} and Rohit Gosain and Anthony Donato and Ranjan Pathak and Bhatt, {Vijaya Raj} and Anjan Katel and Peter Kouides",

year = "2020",

month = jul,

day = "1",

doi = "10.1007/s11886-020-01327-9",

language = "English (US)",

volume = "22",

journal = "Current Cardiology Reports",

issn = "1523-3782",

publisher = "Current Medicine Group",

number = "7",

}

TY - JOUR

T1 - Venous Thromboembolism in COVID-19

T2 - Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment

AU - Aryal, Madan Raj

AU - Gosain, Rohit

AU - Donato, Anthony

AU - Pathak, Ranjan

AU - Bhatt, Vijaya Raj

AU - Katel, Anjan

AU - Kouides, Peter

PY - 2020/7/1

Y1 - 2020/7/1

N2 - Purpose of Review: Novel coronavirus disease 2019 (COVID-19) has been associated with an increased risk of arterial and venous thromboembolic (VTE) diseases. However, there is a limited amount of data regarding the prevention and management of VTE in severe hospitalized COVID-19 patients. Recent Findings: In this article, we review currently available clinical data, and mechanisms for COVID-associated coagulopathy, and propose algorithms for screening, prevention (including extended-duration prophylaxis), and treatment of these patients. Summary: Although these recommendations are subject to change given rapidly evolving data, we provide a framework that can guide clinicians in managing thrombotic complications in this challenging condition.

AB - Purpose of Review: Novel coronavirus disease 2019 (COVID-19) has been associated with an increased risk of arterial and venous thromboembolic (VTE) diseases. However, there is a limited amount of data regarding the prevention and management of VTE in severe hospitalized COVID-19 patients. Recent Findings: In this article, we review currently available clinical data, and mechanisms for COVID-associated coagulopathy, and propose algorithms for screening, prevention (including extended-duration prophylaxis), and treatment of these patients. Summary: Although these recommendations are subject to change given rapidly evolving data, we provide a framework that can guide clinicians in managing thrombotic complications in this challenging condition.

KW - COVID-19

KW - Deep vein thrombosis

KW - Extended prophylaxis

KW - Pulmonary embolism

KW - Thromboprophylaxis

KW - Venous thromboembolism

UR - http://www.scopus.com/inward/record.url?scp=85086321887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85086321887&partnerID=8YFLogxK

U2 - 10.1007/s11886-020-01327-9

DO - 10.1007/s11886-020-01327-9

M3 - Review article

C2 - 32529517

AN - SCOPUS:85086321887

VL - 22

JO - Current Cardiology Reports

JF - Current Cardiology Reports

SN - 1523-3782

IS - 7

M1 - 52

ER -